Protagonist Therapeutics Inc (PTGX)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -93,652 | -131,373 | -125,845 | -64,516 | -80,521 |
| Revenue | US$ in thousands | 60,137 | 26,704 | 27,448 | 27,534 | 118 |
| Operating profit margin | -155.73% | -491.96% | -458.49% | -234.31% | -68,238.14% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-93,652K ÷ $60,137K
= -155.73%
The operating profit margin of Protagonist Therapeutics Inc has shown significant volatility over the past five years. The operating profit margins for the years ending December 31, 2023, and December 31, 2022, were negative at -155.73% and -491.96%, respectively, indicating that the company's operating expenses exceeded its operating income by a substantial margin. The operating profit margin for the year ending December 31, 2021, also remained negative at -458.49%. However, there was a slight improvement in the operating profit margin for the year ending December 31, 2020, though it still remained negative at -234.31%.
Interestingly, the operating profit margin for the year ending December 31, 2019, was abnormally low at -68,238.14%, indicating a significant loss from operations relative to revenue. This aberration raises concerns about the company's operational efficiency and profitability during that specific period.
Overall, the negative operating profit margins observed in recent years suggest that Protagonist Therapeutics Inc has been facing challenges in generating profits from its core business activities. An in-depth analysis of the company's cost structure, revenue streams, and operational strategies may be needed to understand the factors contributing to these unfavorable operating profit margins.
Peer comparison
Dec 31, 2023